drugset / Trial / NCT00935415

Time-Effect of Montelukast Protection

NCT00935415

Phase 4 Completed 69 enrolled University of Verona
RandomizedCrossoverDouble-blindTreatment

Summary

The aim of this study is to verify MNT time of onset of protection against EIB in asthmatic children by evaluating different time intervals between dosing and challenge, after a single-dose and after three days of once a day MNT administration.

Timeline

Start
2007-01
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Montelukast Other / unclassified 5 mg